Drug Shortage Report for TOBI
Report ID | 173402 |
Drug Identification Number | 02239630 |
Brand name | TOBI |
Common or Proper name | TOBRAMYCIN |
Company Name | BGP PHARMA ULC |
Market Status | MARKETED |
Active Ingredient(s) | TOBRAMYCIN |
Strength(s) | 300MG |
Dosage form(s) | SOLUTION |
Route of administration | INHALATION INHALATION |
Packaging size | 56 AMPULES |
ATC code | J01GB |
ATC description | AMINOGLYCOSIDE ANTIBACTERIALS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2022-12-21 |
Actual start date | 2022-11-21 |
Estimated end date | 2023-04-28 |
Actual end date | 2023-04-24 |
Shortage status | Resolved |
Updated date | 2023-05-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2022-11-09 | English | Compare |
v3 | 2022-11-09 | English | Compare |
v2 | 2022-11-03 | French | Compare |
v1 | 2022-11-03 | English | Compare |